"When you need comprehensive healthcare services, close to home, delivered by professionals who combine world-class services with a human touch, Geisinger Medical Center (GMC) is here for you. When you need comprehensive healthcare services, close to home, delivered by professionals who combine world-class services with a human touch, Geisinger Medical Center (GMC) is here for you. Geisinger Medical Center is more than a hospital. It is central Pennsylvania’s most complete healthcare system, offering many services that are not available anywhere else locally. With more than 2,000 healthcare professionals, GMC is the right choice when you need specialized, personalized care."

During the past decade, Geisinger Cancer Institute at Geisinger Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 78 clinical trials were completed, i.e. on average, 3900% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 15 clinical trials were completed. i.e. 1500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Cancer Institute at Geisinger Health" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 42 trials, followed by "Radiation Therapy Oncology Group" with 11 trials sponsored, "Eastern Cooperative Oncology Group" with 10 trials sponsored, "Children's Oncology Group" with 9 trials sponsored and "SWOG Cancer Research Network" with 9 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Cancer Institute at Geisinger Health" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Cancer Institute at Geisinger Health" are "Breast Cancer" (16 trials), "Lung Cancer" (15 trials), "Leukemia" (12 trials), "Lymphoma" (12 trials) and "Esophageal Cancer" (7 trials). Many other conditions were trialed in "Geisinger Cancer Institute at Geisinger Health" in a lesser frequency.

Most popular intervention types in "Geisinger Cancer Institute at Geisinger Health" are "Drug" (77 trials), "Biological" (34 trials), "Radiation" (26 trials), "Other" (25 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (14 trials), "cyclophosphamide" (12 trials), "radiation therapy" (11 trials), "bevacizumab" (8 trials) and "carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Cancer Institute at Geisinger Health" are 83 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Geisinger Cancer Institute at Geisinger Health". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 78 completed trials in Geisinger Cancer Institute at Geisinger Health, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Cancer Institute at Geisinger Health, 2 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".